Intern I - Automation System Engineering jobs in United States
info-icon
This job has closed.
company-logo

Dexcom · 3 days ago

Intern I - Automation System Engineering

Dexcom Corporation is a pioneer in continuous glucose monitoring and is seeking an Intern I in Automation System Engineering. The role involves bringing together robotics, software, and data analytics to build new automated manufacturing lines while collaborating with cross-functional teams to solve problems and improve processes.

DiabetesHealth DiagnosticsMedical DeviceSensor
check
H1B Sponsor Likelynote

Responsibilities

You will bring robotics, software and data analytics together to build new, high speed automated manufacturing lines in a cutting-edge industry
You will work with cross-functional teams to rapidly investigate issues and collaboratively solve problems
You will design, build and test new ideas and deliver high reliability systems for a 24x7 environment

Qualification

RoboticsSoftware debuggingData analyticsSystematic problem solvingTeam collaboration

Required

Requires a high school diploma/certificate or equivalent
Must be a currently enrolled student at an accredited college or university in a STEM discipline with an expected graduation date of December 2026 or later

Benefits

Participation in a targeted Learning Series that encourages professional development topics and provides insight into Dexcom's culture and career opportunities.
Engagement in Social Events, Intern Recognition Awards, Paid Holidays, and more!

Company

Dexcom develops, manufactures, and distributes continuous glucose monitoring systems for diabetes management.

H1B Sponsorship

Dexcom has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (54)
2024 (41)
2023 (67)
2022 (75)
2021 (49)
2020 (36)

Funding

Current Stage
Public Company
Total Funding
$2.16B
Key Investors
RWI Group
2023-05-02Post Ipo Debt· $1B
2020-05-12Post Ipo Debt
2018-11-01Post Ipo Equity· $750M

Leadership Team

leader-logo
Jacob Leach
Chief Operating Officer
linkedin
leader-logo
Matt Dolan
Executive Vice President, Strategy, Corporate Development & Dexcom Labs
linkedin
Company data provided by crunchbase